Excessive apoptosis of podocytes caused by dysregulation of microRNA‐182‐5p and CD2AP confers to an increased risk of diabetic nephropathy
Authors:
- 26 May 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (10) , 16516-16523
Abstract
The functions of miR‐182‐5p in the pathogenesis of diabetic nephropathy (DN) remain largely unclear. Here, we studied the roles and relationship between miR‐182‐5p and CD2AP in the development of DN. We used real‐time polymerase chain reaction (PCR) to compare miR‐182‐5p expression between DN and control groups, while computational analysis and luciferase assays were used to confirm CD2AP as a miR‐182‐5p target. Western blot and real‐time PCR were then used to measure the messenger RNA (mRNA) and protein expression of CD2AP in the presence of miR‐182‐5p. The results showed that miR‐182‐5p was highly expressed in cells isolated from people with DN. In addition, the luciferase activity of cells transfected with wild‐type/mutant CD2AP confirmed CD2AP as a direct target of miR‐182‐5p. The expression levels of CD2AP mRNA and protein were much lower in the DN group compared with that in the normal group. In addition, the expression levels of CD2AP mRNA and protein were evidently increased by a miR‐182‐5p inhibitor, but notably downregulated by miR‐182‐5p mimics or CD2AP small interfering RNA (siRNA). Furthermore, miR‐182‐5p and CD2Ap siRNA significantly reduced the survival rate and viability of transfected cells, while the miR‐182‐5p inhibitor exhibited an opposite effect. These findings indicated the presence of a negative regulatory relationship between miR‐182‐5p and CD2AP in podocytes cells and suggested that the overexpression of miR‐182‐5p contributes to the pathogenesis of DN.Keywords
Funding Information
- Jinan Science and Technology Development Project (201506022)
This publication has 33 references indexed in Scilit:
- MicroRNA-29b Inhibits Diabetic Nephropathy in db/db MiceMolecular Therapy, 2014
- Regulation of TIMP3 in diabetic nephropathy: a role for microRNAsActa Diabetologica, 2013
- High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrolThe International Journal of Biochemistry & Cell Biology, 2012
- A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cellsKidney International, 2011
- The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytesNature Immunology, 2010
- Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditionsKidney International, 2009
- Foxo in the immune systemOncogene, 2008
- Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuriesKidney International, 2006
- Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathyAmerican Journal of Kidney Diseases, 2005
- The functions of animal microRNAsNature, 2004